Omnicell, Inc.

  • Earnings Score
  • Moat Score
  • Safety Score
  • Market Cap $1.18B
  • PE 94
  • Debt $340.72M
  • Cash $398.61M
  • EV $1.12B
  • FCF $151.26M

Earnings

loading chart...

Sales & Net Margins

loading chart...
Earnings$12.53M
EBIT$25.59M
ROE1%
ROA1%
FCF$151.26M
Equity$1.24B
Growth Stability-53%
PE94.29
PEG-15.62
PB0.95
P/FCF7.81
P/S1.06
Price/Cash0.34
Debt/Equity0.27
Debt/FCF2.25
Net Margins1%
Gross Margins42%
Op. Margins2%
Earnings CAGR3%
Sales Growth YoY19%
Sales Growth QoQ9%
Sales CAGR9%
FCF CAGR20%
Equity CAGR15%
Earnings Stability0.02
Earnings Growth YoY-210%
Earnings Growth QoQ84%
Earnings CAGR 5Y-6%
Sales CAGR 5Y6%
FCF CAGR 5Y-4%
Equity CAGR 5Y7%
Earnings CAGR 3Y-7%
Sales CAGR 3Y-7%
FCF CAGR 3Y87%
Equity CAGR 3Y5%
Market Cap$1.18B
Revenue$1.11B
Assets$2.12B
Total Debt$340.72M
Cash$398.61M
Shares Outstanding46.05M
EV1.12B
Earnings Score6%
Moat Score28%
Safety Score63%
Final Score32%
Working Capital219.82M
Current Ratio1.37
Gross Profit$471.00M
Shares Growth 3y2%
Equity Growth QoQ1%
Equity Growth YoY5%

Assets & ROA

loading chart...

Stockholders Equity & ROE

loading chart...
Omnicell provides automation and business analytics software for healthcare providers. The automation and analytics segment manufactures medication dispensing systems, pharmacy inventory management systems, and related software. The medication adherence segment sells products like consumable medication blister cards and packaging equipment to help administer medication outside of a hospital setting. Omnicell generates the vast majority of its revenue in the United States.

SEC Filings

Direct access to Omnicell, Inc. (OMCL) Annual Reports (10K) and Quarterly Reports (10Q) from the SEC website.

  • 2024
    • 10-K Dec 31
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31
  • 2023
    • 10-K Dec 31
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31
  • 2022
    • 10-K Dec 31
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31

Sector Comparison

How does Omnicell, Inc. compare to its competitors?

Loading chart...

Peter Lynch's Chart

This chart shows the current pricing of Omnicell, Inc. compared to its past. The addition of the earnings trend line provides further insights into the company's earnings power.

CAGR 3%
Stability 2%
loading chart...

Omnicell, Inc. Discounted Cash Flow

Fully customizable DCF calculator online for Omnicell, Inc..

= $6B
012345678910TV
fcf$151M$181M$217M$260M$311M$373M$447M$535M$641M$767M$919M$9.2B
DCF$165M$179M$195M$213M$232M$252M$275M$299M$325M$354M$3.5B
Value$6B

Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years12/201512/201612/201712/201812/201912/202012/202112/202212/202312/2024TTM
Net Margins6%0%3%5%7%4%7%0%-2%1%1%
ROA-1%1%4%6%2%4%-0%-1%1%1%
ROE-0%4%6%7%3%7%0%-2%1%1%

Safety and Stability

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years12/201512/201612/201712/201812/201912/202012/202112/202212/202312/2024TTM
Debt over FCF-7.3722.131.740.392.872.4118.734.082.252.25
Debt over Equity00.590.410.210.060.480.430.50.480.270.27
Growth Stability---100%100%81%100%10%-53%60%-53%

Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years12/201512/201612/201712/201812/201912/202012/202112/202212/202312/2024CAGR 5Y
Revenue YoY growth-43%3%10%14%-1%27%14%-11%-3%6%
Earnings YoY growth--98%3K%83%63%-48%142%-93%-461%-162%-6%
Equity YoY growth-7%20%31%24%14%19%-1%5%5%7%
FCF YoY growth-32%-72%746%61%26%24%-85%362%8%-4%